Biomarin Pharmaceutical Inc (BMRN)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 2,830,220 2,731,722 2,563,532 2,443,023 2,373,030 2,261,604 2,184,719 2,123,138 2,059,481 1,999,471 1,903,678 1,871,615 1,827,451 1,829,463 1,891,778 1,815,339 1,822,817 1,822,364 1,813,337 1,772,797
Total assets US$ in thousands 6,988,940 6,851,200 7,067,120 6,872,670 6,841,600 6,758,160 6,563,170 6,433,700 6,375,070 6,264,040 6,145,840 6,062,710 6,004,770 5,977,480 5,898,500 5,805,050 5,848,020 6,158,090 5,302,110 4,722,840
Total asset turnover 0.40 0.40 0.36 0.36 0.35 0.33 0.33 0.33 0.32 0.32 0.31 0.31 0.30 0.31 0.32 0.31 0.31 0.30 0.34 0.38

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $2,830,220K ÷ $6,988,940K
= 0.40

Total asset turnover is a financial ratio that measures a company's ability to generate revenue from its assets. It indicates how efficiently the company is using its assets to generate sales. For Biomarin Pharmaceutical Inc, the total asset turnover ratio has shown fluctuations over the past few years.

From March 31, 2020, to December 31, 2022, the total asset turnover ratio ranged between 0.30 and 0.32, indicating that the company was generating approximately $0.30 to $0.32 in revenue for every dollar of assets it held. This suggests that Biomarin Pharmaceutical Inc was moderately efficient in utilizing its assets to generate sales during this period.

However, from March 31, 2023, to December 31, 2024, the total asset turnover ratio improved, reaching a range of 0.33 to 0.40. This indicates that the company was able to increase its revenue generation relative to its asset base, showing improved asset efficiency during this period.

Overall, Biomarin Pharmaceutical Inc's total asset turnover ratio has shown variability but has demonstrated an upward trend in recent years, suggesting an improvement in the company's ability to generate sales using its asset base.